
| Pair Name | Peiminine, Doxorubicin | ||
| Phytochemical Name | Peiminine (PubChem CID: 167691 ) | ||
| Anticancer drug Name | Doxorubicin (PubChem CID: 31703 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Peiminine, Doxorubicin | |||
| Disease Info | [ICD-11: 2B72.Z] | Gastric cancer | Investigative | |
| Gene Regulation | Down-regulation | Expression | CCND1 | hsa595 |
| Up-regulation | Cleavage | PARP1 | hsa142 | |
| Down-regulation | Expression | EGFR | hsa1956 | |
| Down-regulation | Expression | PTK2 | hsa5747 | |
| In Vitro Model | SGC-7901 | Human papillomavirus-related cervical adenocarcinoma | Homo sapiens (Human) | CVCL_0520 |
| Result | Our findings indicated that sinapine played an important role in the downregulation of MDR1 expression through suppression of fibroblast growth factor receptor (FGFR)4/FRS2α-ERK1/2 mediated NF-κB activation in MCF-7/dox cancer cells. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Peiminine serves as an adriamycin chemosensitizer in gastric cancer by modulating the EGFR/FAK pathway. Oncol Rep. 2018 Mar;39(3):1299-1305. doi: 10.3892/or.2018.6184. | Click |